Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alfonsi

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cytogenetic and Genome Research|November 17, 2011
A new case of pure partial 7q duplicationM Alfonsi, C Palka, E Morizio, et al.
Seminars in Oncology|December 16, 2004
Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)J Bourhis, G Calais, M Lapeyre, et al.
Annales De Dermatologie Et De Venereologie|April 1, 2008
[Interest of a sterilised anti-burning gel in radiation dermatitis: results of a comparative study]V Ribet, S Salas, J M Levecq, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
High-dose methotrexate: a clinical and pharmacokinetic evaluation. Treatment of advanced squamous cell carcinoma of the head and neck using a prospective mathematical model and pharmacokinetic surveillanceR Favre, S Monjanel, M Alfonsi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Cost-Analysis of Complex Radiotherapy in Patients with Head and Neck Cancer Results from the Art-Orl StudyL Perrier, M Morelle, P Pommier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)M Frikha, A Auperin, Y Tao, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 28, 2016
Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancerJ-E Bibault, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2000
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative studyJ C Horiot, F Lipinski, S Schraub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trialY Tao, J Biau, X S Sun, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cytogenetic and Genome Research|November 17, 2011
A new case of pure partial 7q duplicationM Alfonsi, C Palka, E Morizio, et al.
Seminars in Oncology|December 16, 2004
Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)J Bourhis, G Calais, M Lapeyre, et al.
Annales De Dermatologie Et De Venereologie|April 1, 2008
[Interest of a sterilised anti-burning gel in radiation dermatitis: results of a comparative study]V Ribet, S Salas, J M Levecq, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
High-dose methotrexate: a clinical and pharmacokinetic evaluation. Treatment of advanced squamous cell carcinoma of the head and neck using a prospective mathematical model and pharmacokinetic surveillanceR Favre, S Monjanel, M Alfonsi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Cost-Analysis of Complex Radiotherapy in Patients with Head and Neck Cancer Results from the Art-Orl StudyL Perrier, M Morelle, P Pommier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)M Frikha, A Auperin, Y Tao, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 28, 2016
Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancerJ-E Bibault, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2000
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative studyJ C Horiot, F Lipinski, S Schraub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trialY Tao, J Biau, X S Sun, et al.
Pageof 5